What are the Clinical Trials and Research Developments in Mismatch Repair and Cancer?
Ongoing research and clinical trials are exploring novel therapeutic approaches targeting MMR-deficient cancers. These include combination therapies that enhance the efficacy of immunotherapy, as well as new drugs specifically designed to exploit the vulnerabilities of MMR-deficient tumors. The aim is to improve survival rates and quality of life for patients with these high-risk cancers.
